{"id":"NCT01508936","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","briefTitle":"Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma","officialTitle":"A 16-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) Treatment in Patients With Moderate to Severe Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-02","primaryCompletion":"2013-08","completion":"2013-08","firstPosted":"2012-01-12","resultsPosted":"2016-06-27","lastUpdate":"2016-06-27"},"enrollment":511,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Eosinophilic Asthma"],"interventions":[{"type":"DRUG","name":"Reslizumab","otherNames":["Cinquil","humanized monoclonal antibody","CEP-38072"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Reslizumab 3.0 mg/kg","type":"EXPERIMENTAL"}],"summary":"The primary objective of the study is to characterize the efficacy of reslizumab treatment, at a dosage of 3.0 milligrams per kilogram (mg/kg) every 4 weeks for a total of 4 doses, in improving pulmonary function in relation to baseline blood eosinophil levels in patients with moderate to severe asthma, as assessed by the change from baseline to week 16 in forced expiratory volume in 1 second (FEV1).","primaryOutcome":{"measure":"Change From Baseline in Forced Expiratory Volume in 1 Second (FEV1) at Week 16 in Full Analysis Set","timeFrame":"Baseline (Day 1), Week 16","effectByArm":[{"arm":"Placebo","deltaMin":-0.2778,"sd":0.2379},{"arm":"Reslizumab 3.0 mg/kg","deltaMin":0.0229,"sd":0.0944}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2407"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":17},"locations":{"siteCount":66,"countries":["United States"]},"refs":{"pmids":["27018175"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":97},"commonTop":["Asthma","Upper respiratory tract infection","Sinusitis","Bronchitis","Nasopharyngitis"]}}